My Top 15 High-Growth Dividend Stocks returned 8.75% YTD despite July losses, focusing on value and growth. Read why this ...

Shares of the growth stock have soared 40% this year, leaving the S&P 500 in the dust.

This year's losses may not be nearly as deep, but without a significant recovery, the stock may be on track for a decline of more than 20% for just the second time in 10 years.

Intel (NASDAQ:INTC) stock increased almost 7% on Tuesday, despite the absence of significant stock-specific news to justify such a significant movement. The overall semiconductor sector has been ...

RTX stock is expensive when valued on earnings. Valued on free cash flow... it's even more expensive.

Traders have repeatedly shrugged off President Trump’s disruptive tariff wars and fiscal policy, pushing U.S. stock prices back into expensive territory, our columnist says.

Rocket Lab stock surged nearly 32% with the help of bullish coverage from analysts. Citi and Bank of America both reiterated buy ratings on Rocket Lab and raised their respective price targets on ...

While ProKidney’s Phase 2 outcomes signify authentic scientific advancement, the stock’s considerable increase has likely already absorbed much of the favorable news.

Autodesk shares are moving lower in extended trading Wednesday following a report that the company is considering a takeover of a competing engineering-software provider.

Wedbush turned bullish on AMC’s stock, citing a more consistent movie-release slate over the next several quarters and prospects for market-share gains.

UnitedHealth Group is scheduled to report second-quarter results on Tuesday morning, capping a tumultuous first half of the year for the health insurance giant.

Tesla is scheduled to report its second-quarter results after the market closes on Wednesday, with investors expecting the electric vehicle maker's stock could make a sizable move.